Business Wire (Tue, 8:00AM)
Quote & Headlines
Market Currents
StockTalk
Today
5d
1m
3m
1y
5y
10y
52wk high:
52wk low:
EPS:
PE:
Div Rate:
Yield:
Market Cap:
Volume:
HEADLINES:
ALL
|
PRO
|
FOCUS
|
RELATED
|
TRANSCRIPTS
|
NEWS & PR
-
-
Business Wire (May 7, 2013)
-
Business Wire (Apr 30, 2013)
-
Business Wire (Feb 11, 2013)
-
Business Wire (Feb 6, 2013)
-
Business Wire (Jan 30, 2013)
-
Business Wire (Jan 23, 2013)
-
-
Business Wire (Dec 21, 2012)
-
SurModics' CEO Discusses F4Q12 Results - Earnings Call TranscriptTue, Nov 6, 2012
-
Business Wire (Nov 6, 2012)
-
Business Wire (Oct 30, 2012)
-
5 Cash-Loaded Small Cap Stocks With Low To No DebtZetaKap • Fri, Oct 5, 2012 -
Business Wire (Sep 11, 2012)
-
Business Wire (Sep 7, 2012)
-
Business Wire (Sep 6, 2012)
-
7 Liquid Small-Cap Healthcare Stocks Rated Buy Or Better By AnalystsZetaKap • Tue, Aug 28, 2012
To learn more about Seeking Alpha Pro, click here.
-
Earnings Scorecard: SurModicsZacks Investment Research • Thu, May 5, 2011 -
Surmodics: Convergence of Devices and DrugsAlan Brochstein • Tue, Oct 30, 2007 -
SurModics Acquires BioFX Laboratories For $22.7 MillionSara Calabro • Tue, Aug 14, 2007
-
-
5 Cash-Loaded Small Cap Stocks With Low To No DebtZetaKap • Fri, Oct 5, 2012
-
7 Liquid Small-Cap Healthcare Stocks Rated Buy Or Better By AnalystsZetaKap • Tue, Aug 28, 2012
-
8 Highly Liquid Healthcare Stocks Undervalued By EPS TrendsKapitall • Thu, Aug 23, 2012
-
-
-
-
-
-
-
-
-
-
-
-
-
-
7 Healthcare Stocks for a Sick MarketAlan Brochstein • Sun, Jan 6, 2008
-
Three Stocks for a Tough MarketAlan Brochstein • Thu, Sep 6, 2007
-
SurModics' CEO Discusses F4Q12 Results - Earnings Call TranscriptTue, Nov 6, 2012
-
SurModics' CEO Discusses F3Q12 Results - Earnings Call TranscriptWed, Aug 1, 2012
-
SurModics' CEO Discusses F2Q2012 Results - Earnings Call TranscriptTue, May 8, 2012
-
SurModics' CEO Hosts Annual Shareholder Meeting (Transcript)Sun, Feb 19, 2012
-
SurModics' CEO Discusses F4Q 2011 Results - Earnings Call TranscriptFri, Nov 4, 2011
-
SurModics CEO Discusses F3Q2011 Results - Earnings Call TranscriptWed, Aug 3, 2011
-
SurModics' CEO Discusses Q2 2011 Results - Earnings Call TranscriptWed, Apr 27, 2011
-
SurModics CEO Discusses F4Q2010 Results - Earnings Call TranscriptWed, Nov 10, 2010
-
SurModics, Inc., F3Q10 (Qtr End 06/30/2010) Earnings Call TranscriptWed, Jul 28, 2010
-
SurModics, Inc. F2Q10 (Qtr End 03/31/10) Earnings Call TranscriptWed, Apr 28, 2010
-
SurModics, Inc. F1Q10 (Qtr End 12/31/09) Earnings Call TranscriptThu, Jan 28, 2010
-
SurModics, Inc.Q4 2009 Earnings Call TranscriptWed, Nov 4, 2009
-
SurModics Q2 2009 Earnings TranscriptThu, Jul 30, 2009
-
SurModics Inc. F2Q09 (Qtr End 03/31/09) Earnings Call TranscriptThu, Apr 30, 2009
-
SurModics, Inc. F1Q09 (Qtr End 12/31/08) Earnings Call TranscriptWed, Jan 28, 2009
-
Business Wire (Tue, 8:00AM)
-
Business Wire (May 7, 2013)
-
Business Wire (Apr 30, 2013)
-
Business Wire (Feb 11, 2013)
-
Business Wire (Feb 6, 2013)
-
Business Wire (Jan 30, 2013)
-
Business Wire (Jan 23, 2013)
-
Business Wire (Dec 21, 2012)
-
Business Wire (Nov 6, 2012)
-
Business Wire (Oct 30, 2012)
-
at MarketWatch.com (Sep 13, 2012)
-
Business Wire (Sep 11, 2012)
-
Business Wire (Sep 7, 2012)
-
Business Wire (Sep 6, 2012)
-
Business Wire (Aug 27, 2012)
-
at Fox Business (Aug 15, 2012)
-
at Fox Business (Aug 15, 2012)
-
at Fox Business (Aug 15, 2012)
-
Business Wire (Aug 6, 2012)
-
at MarketWatch.com (Aug 2, 2012)
SRDX vs. ETF Alternatives
Company Description
SurModics, Inc. is a leading provider of drug delivery and surface modification technologies to the healthcare industry. Our mission is to exceed our customers’ expectations and enhance the well-being of patients by providing the world’s foremost, innovative drug delivery and surface... More
